Using small molecule compounds, which can effectively dissociate the p53/MDM2 complex and inhibit MDM2 mediated p53 ubiquitination and degradation, inducing the activation and accumulation of wild type p53 in tumor cells. This evidence concerns the gene MDM2 and neoplasm.